A Rare Case of Losartan-Induced Visceral Angioedema
- PMID: 37965705
- PMCID: PMC10647941
- DOI: 10.1177/21501319231213744
A Rare Case of Losartan-Induced Visceral Angioedema
Abstract
The following describes a case of isolated visceral angioedema related to an angiotensin II receptor blocker (ARB) medication. Additionally, we discuss the pathophysiology of drug-induced angioedema, various presentations that can be encountered, and the leading theorized mechanisms of how renin-angiotensin-aldosterone system (RAAS) blocking medications lead to angioedema. The goal of sharing this case is to help increase awareness of the possibility of ARB-induced angioedema and to recommend keeping visceral angioedema as part of the differential diagnosis when presented with a patient who is taking an angiotensin converting enzyme inhibitor (ACEI) or ARB medication that is experiencing gastrointestinal symptoms of unclear etiology.
Keywords: adverse drug reaction; angiotensin receptor blockers; intestinal angioedema; losartan; visceral angioedema.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
